Group 1 - MicroPort Medical (00853) announced the appointment of Jonathan W Chen as the rotating co-CEO effective June 27, 2025, with annual rotation and performance-based adjustments [1] - Brian Yale Chang has been appointed as the Chief Medical Officer, also effective June 27, 2025 [1] - Benoit Clinchamps has been appointed as the Chief Overseas Operations Officer to closely collaborate with the executive management team on robust overseas business support strategies, including market access, quality assurance, regulatory affairs, and supply chain functions [1] Group 2 - To incentivize Brian Chang and Clinchamps for their contributions and to attract and retain talent for the company's ongoing operations and development, the board has granted a total of 3.7 million stock options under the share scheme adopted on June 19, 2023 [2] - Brian Chang has been granted 3.5 million stock options, representing approximately 0.19% of the company's issued share capital, while Clinchamps has been granted 200,000 stock options, representing approximately 0.01% [2]
微创医疗(00853)：Jonathan W Chen已获委任为轮值联席首席执行官